BTC $81,628.70 -0.02%
ETH $2,399.42 -0.14%
BNB $745.43 +1.67%
XRP $1.31 -0.72%
SOL $104.38 -0.27%
TRX $0.3301 -0.09%
DOGE $0.0800 +0.67%
ADA $0.2157 -0.20%
BCH $284.38 +3.20%
LINK $11.99 -0.30%
HYPE $77.68 -0.60%
AAVE $146.88 -0.19%
SUI $0.9914 +0.75%
XLM $0.1759 -0.88%
ZEC $1,224.50 -1.70%
AAPL $350.00 +1.26%
AMZN $248.19 -2.76%
GOOGL $322.63 -2.31%
MSFT $517.27 -2.47%
META $643.15 -1.30%
NVDA $212.34 -2.53%
TSLA $376.11 -0.96%
SNDK $1,285.79 -2.65%
INTC $86.33 -1.85%
SPCX $148.11 -3.57%
MU $878.83 -1.67%
AMD $516.66 -1.27%
BTC $81,628.70 -0.02%
ETH $2,399.42 -0.14%
BNB $745.43 +1.67%
XRP $1.31 -0.72%
SOL $104.38 -0.27%
TRX $0.3301 -0.09%
DOGE $0.0800 +0.67%
ADA $0.2157 -0.20%
BCH $284.38 +3.20%
LINK $11.99 -0.30%
HYPE $77.68 -0.60%
AAVE $146.88 -0.19%
SUI $0.9914 +0.75%
XLM $0.1759 -0.88%
ZEC $1,224.50 -1.70%
AAPL $350.00 +1.26%
AMZN $248.19 -2.76%
GOOGL $322.63 -2.31%
MSFT $517.27 -2.47%
META $643.15 -1.30%
NVDA $212.34 -2.53%
TSLA $376.11 -0.96%
SNDK $1,285.79 -2.65%
INTC $86.33 -1.85%
SPCX $148.11 -3.57%
MU $878.83 -1.67%
AMD $516.66 -1.27%

Quantum BioPharma Q3 Financial Report: Achieved $572,000 in Revenue through Digital Asset Portfolio

2025-11-08 08:53:05

According to GlobeNewswire, Quantum BioPharma (NASDAQ: QNTM) today announced its financial results for the third quarter of 2025, showing a significant improvement in the company's financial condition, with a 275% quarter-over-quarter increase in shareholder equity, a 50% reduction in total liabilities, and an 87% decrease in the debt-to-equity ratio.

The company's digital asset portfolio (primarily consisting of Bitcoin) has realized a gain of $572,000, with the total value of digital assets increasing from $800,000 at the end of 2024 to the current $5.2 million.

app_icon
ChainCatcher Building the Web3 world with innovations.